Primary Article

Frequency of Lipid‐Lowering Drug Therapy After Coronary and Carotid Operations for Atherosclerosis

Authors: CHARLES S. ROBERTS MD, KIMBERLY D. DONOVAN MSN, ANP, PAIGE J. McCARTHY, BLAIR A. KEAGY MD

Abstract

Abstract Background. Coronary artery bypass grafting (CABG) and carotid endarterectomy (CE) are palliative operations for patients with severe atherosclerosis of the coronary or carotid arteries. Secondary preventive measures after these operations have received little attention. Methods. We conducted a retrospective observational study to determine the frequency of lipid‐lowering drug therapy before and after CABG or CE done in 1997. Results. Of the 204 patients who had CABG, 56 (27%) were receiving lipid‐lowering drug therapy before admission, and 71 (37%) of 192 were discharged receiving it. Of the 59 patients who had CE, only 12 (20%) were taking a lipid‐lowering drug before admission, and 8 (14%) upon discharge. Of those 59 patients, 23 (39%) had coronary artery disease. Conclusion. Secondary prevention after coronary or carotid operations for atherosclerosis has been underemphasized at our institution, prompting the establishment of a postoperative risk reduction program.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References